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Abstract
Background: This study was undertaken to investigation the effect of Diasulin, a poly herbal drug
composed of ethanolic extract of ten medicinal plants on blood glucose, plasma insulin, tissue lipid
profile, and lipidperoxidation in alloxan induced diabetes.
Methods: Ethanolic extract of Diasulin a, poly herbal drug was administered orally (200 mg/kg
body weight) for 30 days. The different doses of Diasulin on blood glucose and plasma insulin in
diabetic rats were studied and the levels of lipid peroxides [TBARS, and Hydroperoxide] and tissue
lipids [cholesterol, triglyceride, phospholipides and free fatty acids] were also estimated in alloxan
induced diabetic rats. The effects were compared with glibenclamide.
Result: Treatment with Diasulin and glibenclamide resulted in a significant reduction of blood
glucose and increase in plasma insulin. Diasulin also resulted in a significant decrease in tissue lipids
and lipid peroxide formation. The effect produced by Diasulin was comparable with that of
glibenclamide.
Conclusion: The decreased lipid peroxides and tissue lipids clearly showed the antihyperlipidemic
and antiperoxidative effect of Diasulin apart from its antidiabetic effect.
Background
Diabetes mellitus is syndrome, initially characterized by a
loss of glucose homeostasis resulting from defects in insu-
lin secretion, insulin action both resulting impaired
metabolism of glucose and other energy- yielding fuels
such as lipids and protein [1]. Experimental diabetes in
animals has provided considerable insight into the physi-
ologic and biochemical derangement of the diabetic state.
Many of the derangement have been characterized in
hyperglycemic animals. Significant changes in lipid
metabolism and structure also occur in diabetes [2]. In
these cases the structural changes are clearly oxidative in
nature and are associated with development of vascular
disease in diabetes [3]. In diabetic rats, increased lipidper-
oxidation was also associated with hyperlipidemia [4].
Liver, an insulin dependent tissue that plays a pivotal role
in glucose and lipid homeostasis and it is severely affected
during diabetes [5]. Liver and kidney participates in the
uptake, oxidation and metabolic conversion of free fatty
acids, synthesis of cholesterol, phospholipids, and triglyc-
erides. During diabetes, a profound alteration in the con-
centration and composition of lipids occurs.
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Despite the great strides that have been made in the
understanding and management of diabetes, the disease
and disease related complications are increasing unabated
[6]. Inspite of the presence of known antidiabetic medi-
cine in the pharmaceutical market, remedies from medic-
inal plants are used with success to treat this disease [7].
Many traditional plant treatments for diabetes are used
throughout the world. Plant drugs [8] and herbal formu-
lation [9-11] are frequently considered to be less toxic and
more free from side effects than synthetic one. Based on
the WHO recommendations hypoglycemic agents of
plant origin used in traditional medicine are important
[12]. The attributed antihyperglycemic effects of these
plants is due to their ability to restore the function of pan-
creatic tissues by causing an increase in insulin output or
inhibit the intestinal absorption of glucose or to the facil-
itation of metabolites in insulin dependent processes.
Hence treatment with herbal drugs has an effect on pro-
tecting β -cells and smoothing out fluctuation in glucose
levels [13,14]. In general, there is very little biological
knowledge on the specific modes of action in the treat-
ment of diabetes, but most of the plants have been found
to contain substances like glycosides, alkaloids, terpe-
noids, flavonoids etc., that are frequently implicated as
having antidiabetic effects [15]. In the traditional system
of Indian medicine, plant formulation and combined
extracts of plants are used as drug of choice rather than
individual. Various herbal formulations such as diamed
[16], coagent db [17] and hyponidd [18], are well known
for their antidiabetic effects. Diasulin is a poly herbal drug
composed of ten medicinal plants (Table 1), which are
already reported for their antidiabetic activity. In our pre-
vious study, we have demonstrated the antidiabetic effect
of Diasulin in alloxan diabetic rats [19]. The present inves-
tigation was undertaken to study the effect of the potential
antidiabetic herbal formulation, Diasulin on lipidperoxi-
dation and tissue lipid profile in alloxan diabetic rats. The
effects produced by this drug on different parameters were
compared with glibenclamide, a reference drug.
Methods
Experimental animals
Male Wistar rats of body wt. 180–200 g were obtained
from central Animal House, Raja Muthiah Medical Col-
lege, Annamalai University. The animals were fed on
standard pellet diet (Hindustan Lever, Mumbai, India)
and water ad libitum. The rats used in the present study
were maintained in accordance with guidelines of the
National Institute of Nutrition, Indian Council of Medical
Research, Hyderbad, India and the study approved by the
ethical committee (Vide No: 88, 2002).
Drug and chemicals
Ethanolic extract of ten medicinal plants, which are
involved in preparation of Diasulin, was a gift from herbal
remedies, Pondicherry, India.
The residual extracts of the antidiabetic plants were mixed
and named as Diasulin was prepared (Table 1) on the
basis of an ayurvedic antidiabetic formulation proposed
by Pandey et al. (1995) [20]. 500 g of each plant (chopped
into small pieces) was extracted individually were, soaked
overnight in 1.5 litres of 95% ethanol. This suspension
was filtered and the residue was resuspended in an equal
volume of 95% ethanol for 48 h and filtered again. The
two filtrates were pooled and the solvents were evapo-
rated in a rotavapor at 40° – 50°C under reduced pressure
and lyophilized. Alloxan monohydrate was purchased
from BDH Chemicals, Poole, England. Enzyme linked
immunosorbant assay (ELISA) kit for insulin assay was
purchased from Boehringer Mannheim, Germany. All
other biochemicals used in this experiment were pur-
chased from Sigma Chemical Company Inc., St Louis, Mo,
and USA. The chemicals were analytical grade.
Table 1: Diasulin (Composition and concentration)
SI. No Botanical name Common name Family Part used Concentration 
(mg/dL)
1 Cassia auriculata Tanner's cassia Ceasalpinaceae Flower 40
2 Coccinia indica Little gourd Cucurbitaceae Fruit 40
3 Curcuma longa Turmeric Zingiberaceae Rhizome 40
4 Emblica officinalis Indian gooseberry Euphorbiaceae Fruit 20
5 Gymnema sylvestre Ram's horn Asclepiadaceae Leaves 20
6 Momordica charantia Bitter gourd Cucurbitaceae Fruit 30
7 Scoparia dulcis Sweet broom weed Scrophulariaceae Whole Plant 40
8 Syzigium cumini Jamun Myrtaceae Seed 20
9 Tinospora cardifolia Gulancha tinospora Menispermaceae Root 20
10 Trigonella foenum 
graecum
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Drug administration
Diasulin was suspended in distilled water and adminis-
tered orally through intragastric tube at the following
doses of 50, 100 and 200-mg/kg body weight.
Experimental induction of diabetes in rats
The rats were injected intraperitoneally with alloxan
monohydrate dissolved in sterile normal saline at a dose
of 150 mg/kg body wt [21]. After 2 weeks, rats with mod-
erate diabetes having glycosuria (indicated by Benedict's
qualitative test) and hyperglycemia (i.e. with a blood glu-
cose of 200–300 mg/dl) were used for the experiment.
Experimental design
In the experiment, a total of 42 rats (30 diabetic surviving
rats, 12 normal rats) were used. The rats were divided into
seven groups of six rats each after the induction of alloxan
diabetes. Group1: Normal treated rats. Group2: Normal
rats given aqueous solution of Diasulin (200 mg/kg body
weight) daily using an intragastric tube for 30 days. Group
3: Diabetic control rats. Group 4: Diabetic rats given aque-
ous solution of Diasulin (50 mg /kg body weight) daily
using an intragastric tube for 30 days. Group 5: Diabetic
rats given aqueous solution of Diasulin (100 mg /kg body
weight) daily using an intragastric tube for 30 days. Group
6: Diabetic rats given aqueous solution of Diasulin (200
mg /kg body weight) daily using an intragastric tube for
30 days. Group 7: Diabetic rats given aqueous solution of
glibenclamide (600 µg/kg body weight) daily using an
intragastric tube for 30 days.
At the end of 30 days, all the rats were killed by decapita-
tion under pentobarbitone sodium (60 mg/kg) anaesthe-
sia. Blood was collected in tubes containing potassium
oxalate and sodium fluoride solution for the estimation of
blood glucose and plasma was separated for the assay of
insulin. Liver and kidney were immediately dissected out,
washed in ice-cold saline to remove the blood. The tissues
were weighed and 10% tissue homogenate was prepared
with 0.025 M Tris – Hcl buffer, pH 7.5. After centrifuga-
tion at 200 rpm for 10 min, the clear supernatant was used
to measure thiobarbituric acid reactive substances
(TBARS) and hydroperoxides. For the determinations of
lipids the liver and kidney tissues were weighed and lipids
were extracted from tissues by the method of Folch et al
[22] using chloroform – methanol mixture (CHCl3:
MeOH)(2:1 v/v).
Biochemical analysis
Estimation of blood glucose and plasma insulin
Blood glucose was determined by the O-toluidine method
[23]. Plasma insulin was assayed by ELISA, using Boe-
heringer- Mannheim Kit with a Boeheringer analyser
ES300.
Estimation of lipid peroxidation
Lipid peroxidation in liver and kidney were estimated
colorimetrically by thiobarbituric acid reactive substances
TBARS and hydroperoxides by the method of Niehius and
Samuelsson [24] and Jiang et al. [25], respectively. In
brief, 0.1 ml of tissue homogenate (Tris-Hcl buffer, pH
7.5) was treated with 2 ml of (1:1:1 ratio) TBA-TCA-HCl
reagent (thiobarbituric acid 0.37%, 0.25 N HCl and 15%
TCA) and placed in water bath for 15 min, cooled. The
absorbance of clear supernatant was measured against ref-
erence blank at 535 nm.
0.1 ml of tissue homogenate was treated with 0.9 ml of
Fox reagent (88 mg butylated hydroxytoluene (BHT), 7.6
mg xylenol orange and 9.8 mg ammonium ion sulphate
were added to 90 ml of methanol and 10 ml 250 mM sul-
phuric acid) and incubated at 37°C for 30 min. The color
developed was read at 560 nm colorimetrically.
Hydroperoxides was expressed as mM/100 g tissue.
Estimation of lipids
Lipids were extracted from tissues by the method of Folch
et al [22] using chloroform – methanol mixture (CHCl3:
MeOH) (2:1 v/v). The total cholesterol was estimated by
the method of zlatkis et al [26]. To 0.1 ml of the lipid
extract, 9.9 ml of ferric chloride-acetic acid reagent was
added and allowed to stand for 15 min and then centri-
fuged. To 5 ml of the supernatant, add 3 ml of Conc.
H2So4. The colour developed was read after 20 min at 560
nm against a reagent blank. Values were expressed as mg/
100 g tissue.
Triglycerides were estimated by the method of foster and
Dunn [27]. To an aliquot of lipid extract, evaporated to
dryness. 0.1 ml of methanol was added followed by 4 ml
of isopropanol. 0.4 g of alumina was added to all the
tubes and shaken well for 15 min. Centrifuged and then 2
ml of the supernatant was transferred to labeled tubes.
The tubes were placed in a water bath at 65°C for 15 min
for saponification after adding 0.6 ml of the saponifica-
tion reagent followed by 0.5 ml of acetyl acetone reagent.
After mixing, the tubes were kept in a water bath at 65°C
for 1 h, the contents were cooled and absorbance was read
at 420 nm. The triglyceride content was expressed as mg/
100 g tissue.
Phospholipid content was determined by the method of
Zilversmit et al [28]. To 0.1 ml of lipid extract, added 1 ml
of 5 N H2SO4 and 1 ml of concentrated nitric acid and
digested to a colourless solution. The phosphorus content
in the extract was determined by the method of Fiske and
Subba Row [29]. The values were expressed as g/100 g
tissue.BMC Complementary and Alternative Medicine 2005, 5:14 http://www.biomedcentral.com/1472-6882/5/14
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Free fatty acids were estimated by the method of Falholt et
al [30]. 0.1 ml of lipid extract was evaporated to dryness.
1 ml of phosphate buffer, 6 ml of extraction solvent and
2.5 ml of copper reagent were added. All the tubes were
shaken vigorously. 200 mg of activated silicic acid was
added and left aside for 30 min. The tubes were centri-
fuged and 3 ml of the copper layer was transferred to
another tube containing 0.5 ml of diphenyl carbazide and
mixed carefully. The absorbance was read at 550 nm
immediately. The amount of free fatty acids was expressed
as mg/100 g tissue.
Statistical analysis
The data for various biochemical parameters were ana-
lysed using analysis of variance (ANOVA) and the group
means were compared by Duncan's Multiple Range Test
(DMRT). Values were considered statistically significant
when at p < 0.05 [31].
Results
Table 2 shows the level of blood glucose and plasma insu-
lin in control and experimental animals. There was a sig-
nificant elevation in blood glucose level with significant
decrease in plasma insulin levels in alloxan diabetic rats,
compared with normal rats. Administration of Diasulin
and glibenclamide tended to bring blood glucose and
plasma insulin towards near normal levels. The effect of
Diasulin at 200 mg /kg was significantly better than 50
and 100 mg/kg, therefore the higher dose was used for fur-
ther biochemical studies. The administration of Diasulin
and glibenclamide to normal rats showed a significant
effect in lowering blood glucose and increasing plasma
insulin.
Table 3 represents the concentration of TBARS and
hydroperoxides in tissues of control and experimental
animals. There was a significant elevation in tissue TBARS
and hydroperoxides during diabetes, when compared to
the corresponding control group. Administration of
Diasulin and glibenclamide tends to bring the values to
near normal.
Table 4 and 5 shows the levels of cholesterol, triglycerides,
free fatty acids and phospholipids in liver and kidney of
control and experimental rats respectively. Liver and kid-
ney of diabetic rats showed significantly increased levels
Table 2: Changes in blood glucose and plasma insulin levels of control and experimental animals
Groups fasting blood glucose (mg/dL) Plasma insulin (µU / mL)
Normal 81.58 ± 2.40a 11.18 ± 0.74 a
Normal 81.58 ± 2.40a 11.18 ± 0.74 a
Diabetic control 265.00 ± 24.40b 3.55 ± 0.38 c
Diabetic + Diasulin (50 mg/kg) 210.80 ± 14.26c 5.61 ± 0.48d
Diabetic + Diasulin (100 mg/kg) 158.33 ± 11.00d 6.03 ± 0.41d
Diabetic + Diasulin (200 mg/kg) 104.16 ± 6.70e 7.05 ± 0.64e
Diabetic + Glibenclamide (600 µg/kg) 111.60 ± 9.86e 6.32 ± 0.55de
Values are given as mean ± S.D for 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
Duncan procedure, Range for the level 2.89, 3.03, 3.13, 3.20, 3.25.
Diabetic control was compared with normal, † p < 0.001.
Experimental groups were compared with diabetic control, * p < 0.001.+ + +, > 2% sugar, ++; -2% sugar; +, -1%
Table 3: Changes in levels of Tbars and hydroperoxides in liver and kidney of control and experimental animals
Groups TBARS (mM / 100 g tissue) Hydro peroxide (mM / 100 g tissue)
Liver Kidney Liver Kidney
Normal 0.73 ± 0.066a 0.845 ± 0.07a 71.42 ± 4.61a 53.56 ± 4.61a
Normal + Diasulin (200 mg/ kg) 0.72 ± 0.079a 0.785 ± 0.065a 69.63 ± 6.09a 52.40 ± 3.90a
Diabetic control 1.77 ± 0.06b 1.565 ± 0.105b 102.37 ± 6.41b 75.35 ± 4.46b
Diabetic + Diasulin (200 mg/kg) 0.88 ± 0.053c 0.970 ± 0.072c 78.56 ± 5.83c 61.89 ± 6.07c
Diabetic + Glibenclamide (600 µg/kg) 0.93 ± 0.088c 1.00 ± 0.086c 80.90 ± 5.32c 63.16 ± 6.30c
Values are given as mean ± S.D for 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
Duncan procedure, Range for the level 2.95, 3.09, 3.20.BMC Complementary and Alternative Medicine 2005, 5:14 http://www.biomedcentral.com/1472-6882/5/14
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of cholesterol, triglycerides, free fatty acids and phosphol-
ipids, when compared with normal rats. In rats treated
with Diasulin and glibenclamide there was a significant
decrease in the content of cholesterol, triglycerides, free
fatty acids and phospholipids in both the tissues, when
compared with diabetic control rats.
Discussion
Diabetes mellitus is one of the most common chronic dis-
ease and is associated with hyperlipidemia and co-mor-
bidities such as obesity, hypertension. Hyperlipidemia is
a metabolic complications of both clinical and experi-
mental diabetes [32]. Alloxan, a beta cytotoxin, induces
"chemical diabetes" (alloxan diabetes) in a wide variety of
animal species by damaging the insulin secreting
pancreatic  -cell, resulting in a decrease in endogenous
insulin release, which paves the ways for the decreased uti-
lization of glucose by the tissues [33]. In our study, we
have observed that Diasulin decreases blood glucose in
alloxan diabetic rats. The possible mechanism of action of
extract could be correlated with the reminiscent effect of
the hypoglycemic sulphonylureas that promote insulin
secretion by closure of K+-ATP channels, membrane depo-
larization and stimulation of Ca2+ influx, an initial key
step in insulin secretion. In this context, number of other
plants has also been reported to have antihyperglycemic
and insulin stimulatory effects [34,35]. Like the plant
extract, glibenclamide also produced significant reduction
in blood glucose levels of alloxan diabetic rats. Since
alloxan is known to destroy pancreatic β -cells, the present
findings appear to be in consonance with the earlier sug-
gestion of Jackson and Bressler [36] that sulphonylureas
have extra- pancreatic antihyperglycemic mechanism of
action secondary to their insulin secreting effect and the
attendant glucose uptake into, and utilization by, the
tissues.
Apart from the regulation of carbohydrate metabolism,
insulin also plays an important role in the metabolism of
lipids. Insulin is potent inhibitor of lipolysis. Since it
inhibits the activity of the hormone sensitive lipases in
adipose tissue and suppresses the release of free fatty acids
[37]. During diabetes, enhanced activity of this enzyme
increases lipolysis and releases more free fatty acids in to
the circulation [38]. Increased fatty acids concentration
also increases the β -oxidation of fatty acids, producing
more acetyl CoA and cholesterol during diabetes.
Table 4: Changes in levels of cholesterol, free fatty acids, triglycerides and phospholipids in liver of control and experimental animals
Groups Cholesterol 
(mg/100 g wet tissue)
Free fatty acids 
(mg/100 g wet tissue)
Triglycerides 
(mg/100 g wet tissue)
Phospholipids 
(mg/100 g wet tissue)
Normal 328.90 ± 18.90a 606.10 ± 21.76a 344.50 ± 23.20a 1598.00 ± 19.30a
Normal + Diasulin (200 mg/ kg) 321.25 ± 5.74a 601.93 ± 19.00a 341.10 ± 21.00a 1593.10 ± 24.10a
Diabetic control 517.33 ± 13.10b 921.60 ± 44.60b 622.50± 18.80b 1858.60 ± 18.70b
Diabetic + Diasulin (200 mg/kg) 421.75 ± 17.54c 769.16± 13.30c 456.25 ± 17.30c 1718.80 ± 14.40c
Diabetic + Glibenclamide(600 µg/kg) 445.00 ± 9.79c 802.80 ± 53.77c 530.80 ± 35.70d 1769.30 ± 17.60c
Values are given as mean ± S.D for 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
Duncan procedure, Range for the level 2.95, 3.09, 3.20.
Table 5: Changes in levels of cholesterol, free fatty acids, triglycerides and phospholipids in kidney of control and experimental 
animals
Groups Cholesterol 
(mg/100 g wet tissue)
Free fatty acids 
(mg/100 g wet tissue)
Triglycerides 
(mg/100 g wet tissue)
Phospholipids 
(mg/100 g wet tissue)
Normal 375.90 ± 16.58a 434.01 ± 11.50a 282.50 ± 14.70a 1447.60 ± 26.90a
Normal + Diasulin (200 mg/ kg) 371.08 ± 8.28a 432.51 ± 11.60a 278.75 ± 14.60a 1442.50 ± 43.30a
Diabetic control 546.90 ± 23.80b 743.00 ± 25.70b 501.10 ± 34.10b 2041.50 ± 33.69b
Diabetic + Diasulin (200 mg/kg) 435.20 ± 12.18c 556.80 ± 38.50c 382.90 ± 9.28c 1684.00 ± 28.80c
Diabetic + Glibenclamide (600 µg/kg) 449.90 ± 13.49c 600.30 ± 33.40d 438.66 ± 39.30d 1819.30 ± 34.70d
Values are given as mean ± S.D for 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
Duncan procedure, Range for the level 2.95, 3.09, 3.20.
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In normal condition, insulin increases the receptor-medi-
ated removal of LDL-cholesterol and decreased activity of
insulin during diabetes causes hypercholestrolemia.
Hypercholestrolemia and hypertriglycridemia have been
reported to occur in diabetic rats [39]. The increased con-
centration of cholesterol could result in a relative
molecular ordering of the residual phospholipids result-
ing in a decrease in membrane fluidity [40]. The increased
concentration of free fatty acids in liver and kidney may be
due to lipid breakdown and this may cause increased gen-
eration of NADPH, which results in the activation of
NADPH dependent microsomal lipid peroxidation. Liver
and kidney phospholipids were increased in diabetic con-
trol rats. Phospholipids is present in cell membrane and
make up vast majority of the surface lipoprotein forming
a lipid bilayer that acts as an interface with both polar
plasma environment and non-polar lipoprotein of lipo-
protein core [41]. Phospholipids are vital part of biomem-
brane rich in PUFA, which are susceptible substrate for
free radicals such as O2
•- and OH• radicals [42]. Increased
phospholipids levels in tissues were reported by [43,44]
in streptozotocin diabetic rats. Administration of Diasulin
decreased the levels of tissue free fatty acids and
phospholipids.
Accumulation of triglycerides is one of the risk factors in
Coronary Heart Disease (CHD). The significant increase
in the level of triglycerides in liver and kidney of diabetic
control rats may be due to the lack of insulin. Since under
normal condition, insulin activates the enzyme lipopro-
tein lipase and hydrolysis triglycerides [45]. Diasulin
reduces triglycerides in tissues of alloxan-induced diabetic
rats and may prevent the progression of CHD.
The results show increased lipid peroxidation in the tis-
sues (liver and kidney) of diabetic control group. Previous
studies have reported that there was an increased lipid
peroxidation in liver, kidney and brain of diabetic rats
[46,47]. This may be because the tissues contain relatively
high concentration of easily peroxidizable fatty acids.
Liver during diabetes, showed a relatively severe impair-
ment in antioxidant capacity than kidney. The kidney
exhibits a characteristic pattern of changes during diabetes
[48]. The increase in oxygen free radicals in diabetes could
be primarily due to increase in blood glucose levels, which
upon autoxidation generate free radicals and secondarily
due to the effects of diabetogenic agent alloxan [49]. In
diabetes, hypoinsulinaemia increases the activity of the
enzyme, fatty acyl coenzyme, coenzyme A oxidase, which
initiates β -oxidation of fatty acids resulting in lipid perox-
idation [50,51] Increased lipid peroxidation impairs
membrane functions by decreasing membrane fluidity,
and changing the activity of membrane-bound enzymes
[51]. Its products (lipid radicals and lipid peroxide) are
harmful to the cells in the body and are associated with
atherosclerosis and brain damage [51]. Administration of
Diasulin and glibenclamide reduced the lipid peroxida-
tive markers in liver and kidney tissues of diabetic rats.
This indicates that Diasulin inhibit oxidative damage due
to the antiperoxidative effect of ingredients present in
Diasulin. This could be correlated with previous study
that reported that Cassia auriculata [52,53],  Syzigium
cumini [54,55]Tinospora cardifolia [56], and Scoparia dulcis
[57] (ingredients of Diasulin) have antiperoxidative and
antihyperlipidemic effect of diabetic animals.
Antidiabetic and antihyperlipidemic effect of Diasulin
may be due to the effect of active constituents of different
plants, viz, alkaloid and pectins from Coccinia indica [58]
alkaloids from Tinospora cordifolia [59], emlicanin A and B
from Emblica officinalis [60], trigonelline and scopoltin
from Trigonella foenum graecum [61], alkaloid-6-methoxy-
benzoxazolinone and terpenoids such as scoparic acids
A,B,C and scopadulcic acid A and B from 'scoparia dulcis'
[62], which may be responsible for scavenging free radi-
cals liberated by alloxan in diabetic rats.
On the basis of above results, it could be concluded that
Diasulin, a combination of ten herbal plants exert a signif-
icant antihyperlipidemic and antiperoxidative effect. This
could be due to different types of active principles, each
with a single or a diverse range of biological activities,
which serves as a good adjuvant in the present armamen-
tarium of antidiabetic drug.
Conclusion
The liver and kidney exhibits numerous morphological
and functional alterations during diabetes. Since both dia-
betes and hyperlipidemia are considered to be major risk
factors for the premature atherosclerosis and essentially
all the cholesterol in atherosclerotic plaques is derived
from that of circulatory cholesterol. The antihyperlipi-
demic and antiperoxidative effect of Diasulin in particular
could be considered as of possible therapeutic value.
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